Perceived Effectiveness of Stem Cell Injections in Adults with Joint Injuries by Merrill, Delaney Marie
University of South Carolina 
Scholar Commons 
Senior Theses Honors College 
Spring 2020 
Perceived Effectiveness of Stem Cell Injections in Adults with 
Joint Injuries 
Delaney Marie Merrill 
University of South Carolina, delaneymm15@gmail.com 
Follow this and additional works at: https://scholarcommons.sc.edu/senior_theses 
 Part of the Alternative and Complementary Medicine Commons, Musculoskeletal, Neural, and Ocular 
Physiology Commons, Other Rehabilitation and Therapy Commons, and the Physical Therapy Commons 
Recommended Citation 
Merrill, Delaney Marie, "Perceived Effectiveness of Stem Cell Injections in Adults with Joint Injuries" 
(2020). Senior Theses. 317. 
https://scholarcommons.sc.edu/senior_theses/317 
This Thesis is brought to you by the Honors College at Scholar Commons. It has been accepted for inclusion in 
Senior Theses by an authorized administrator of Scholar Commons. For more information, please contact 
dillarda@mailbox.sc.edu. 

Effectiveness of Stem Cell Injections  2 
 
Table of Contents 




 Participants……………………………………………………………………………. 9 
 Procedures…………………………………………………………………………….. 9 
















Effectiveness of Stem Cell Injections  3 
 
Thesis Summary 
Osteoarthritis, which is caused by wear and tear on the joints, is a chronic disease that 
plagues many people and costs the healthcare system billions each year. There is no cure and 
traditional treatments lifestyle changes, pain management medications, and surgery all have 
limitations. However, stem cell therapy is new type of medical treatment that has recently 
become more popular due to its potential to treat osteoarthritis and other joint injuries by 
regenerating cartilage.   
Stem cell therapy is when stem cells are harvested from a patient’s bone marrow or taken 
from a donor or umbilical cord blood. Then, they are injected into the injured area of the body to 
help heal any damage. Stem cells, which are not very prominent in adults, are used because they 
have the ability to become any type of cell in the body. This study focused on the effectiveness 
of stem cell injections in joints, specifically the hip, knee, and shoulder by having participants 
complete a survey. Twenty-nine people filled out the survey which asked about treatment 
protocols, pre and post-treatment pain and mobility levels, and success of the stem cell injection.   
Overall, the study found that 77% of people believed the stem cell treatment to be 
successful and that 72% would recommend it to someone with a similar injury to him or herself. 
Participants also self-reported less pain, increased levels of mobility, a better overall quality of 
life following the stem cell injection. Although the sample size in this study was small, the 
research was able to demonstrate the need for further research on stem cell therapy with more 
patients and over a longer period of time. Additionally, it shows that stem cells have the potential 
to be a standard treatment for people with osteoarthritis and joint injuries.  
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Abstract 
Introduction: Osteoarthritis plagues around 27 million Americans. Stem cell injections are a 
new method of treatment that could potentially cure this by regenerating cartilage in joints. 
Purpose: The purpose of this study is to examine the perceived effectiveness of stem cells at 
regenerating cartilage in joints, specifically the knees, hips, and shoulders. Methods: 
Participants were recruited via social media, forums, and from healthcare clinics that offer stem 
cell treatments. They were asked to complete a survey focusing primarily on the treatment 
protocol and how the injured joint felt post-stem cell injection. Frequencies were calculated to 
describe problematic joints, treatment history, and perceived effectiveness of the stem cell 
therapy. Results: Twenty-nine people participated in the study. Most were white (93.1%), non-
Hispanic or Latino (96.6%), and struggling with an injury due at least in part to degeneration 
(58.6%). Sixty-six percent were female and 48.3% were between 61 and 75 years old. Fifty-five 
percent of participants received the injection in the knee, 13% in the shoulder, 8% in the back 
and 11% in the hip. Most had tried at least one other treatment such as physical therapy 
unsuccessfully prior. Eighty-three percent of people followed a protocol or schedule from their 
doctor, which included stem cells with other therapies like platelet rich plasma. Overall, 77% 
reported success with the stem cell treatment and 72% of the participants would recommend 
stem cell injections to someone with a similar injury to themselves. Conclusion: Stem cells were 
perceived to be beneficial for the majority of participants in the study. This study was performed 
on a small scale so conclusions about effectiveness in general cannot be made. Future studies 
should examine cartilage regeneration for a longer time and on a larger scale with assessments, 
including an x-ray or MRI. The evaluations should be performed both prior to and after the stem 
cell injection.  
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Introduction 
 Aging is a process that everyone experiences and a major component of this is the body 
breaking down physically. The muscles start to atrophy, the metabolic rate slows, the immune 
system does not fight off diseases as well, and joints wear down. The deterioration associated 
with aging may be magnified if one experienced injuries growing up or was extremely active 
(Noth et al., 2008). For many of these problems, doctors have found solutions or treatments such 
as light weightlifting to reduce muscle atrophy or certain diets to increase metabolism, but joint 
and cartilage wear and tear has been not been as straightforward to treat (Noth et al., 2008). 
Although different treatments and surgical options exist, none of them have had widespread 
success because cartilage is very difficult to regrow (Paschos et al., 2017). Cartilage is found in 
between the vertebral discs, in the joints, and ligaments as well as other places in the body. 
Injuries from trauma or overuse are challenging to heal when there is a lack of blood supply and 
since cartilage is avascular, it is challenging to heal or regrow. 
 Osteoarthritis, the most common type of arthritis, is a disease caused by wear and tear on 
the joints that affects an estimated 27 million Americans (McIntyre et al., 2018). It occurs 
primarily in the middle aged and elderly causing inflammation, breakdown of cartilage, changes 
in bone growth, and deterioration of muscles, tendons, and ligaments (Mecoli, 2019). Some 
people are predisposed to developing it due to family history, genetics, and past injuries. Women 
are also more likely to be diagnosed with osteoarthritis than men (CDC OA, 2020). Since the 
disease causes joint pain and stiffness, it often limits people’s day to day activities and makes 
them less likely to participate in physical activity (Rosemann et al., 2008 ). Once one stops 
exercising, they are more likely to suffer from other chronic diseases such as obesity, 
hypertension, and heart disease (Rosemann et al., 2008). People suffering from chronic diseases 
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put an enormous strain on the healthcare system. Osteoarthritis was the second most expensive 
health condition treated in United States hospitals in 2013, accounting for 16.5 billion of the 
combined costs for all hospitalizations (CDC Costs, 2020).  Currently, there is no cure for 
osteoarthritis; therefore, the only treatment options are pain management medications and 
strategies for slowing the progression of the disease (Mecoli, 2019). Treatment recommendations 
include exercise to help reduce stiffness and maintain mobility, weight management, 
pharmacological treatments, using braces and orthotics, and as a last resort surgery (Zhang et al., 
2007). The primary surgical option for treating osteoarthritis, unless one is very young, is a joint 
replacement, which is expensive and has a long recovery time. When a young person has 
osteoarthritis, there are some more conservative surgeries that can performed to temporarily 
delay joint replacement surgery (CDC OA, 2020). The reason OA is so hard to treat is because it 
is very difficult to regenerate cartilage. That being said, medicine is constantly evolving and new 
studies are published almost daily.  
 Currently, regenerative medicine or the study of the regeneration of cells, tissues, and 
organs is a field that is on the rise (Singh, 2017). There are many types of regenerative medicine 
treatments including stem cell therapy, cartilage regeneration surgery, prolotherapy, and platelet 
rich plasma or PRP injections (Singh, 2017).  These treatments can be used on their own or in 
conjunction with each other. While all of these are fairly new medical innovations, they are 
being researched extensively since they are more natural ways of healing the body than surgery 
and can help with diseases or problems associated with aging (Singh, 2017).  
 In the past few years though, one new experimental treatment that seems extremely 
promising has risen to the forefront of regenerative medicine- stem cell transplants. In a stem cell 
transplant, stem cells generally are harvested from the patient’s bone marrow or a donor’s stem 
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cells are used (McIntyre et al., 2018). Then, they are injected into the area where cartilage is 
worn away, such as the knee joint, or an injury to cartilage has occurred, like a torn meniscus. 
The stem cells help the cartilage in the joint to regenerate so the person no longer experiences the 
pain of the two bones rubbing together and can avoid a meniscus repair or different type of 
orthopedic surgery (Paschos et al., 2017).  
 Stem cells are used for this treatment because they are undifferentiated cells that can 
serve various functions and can differentiate into a muscle cell (Cafasso, 2016). The majority of 
cells in the body are already differentiated for a specific job and break down after they divide a 
few times (Cafasso, 2016). As one ages, the cells decrease in their degree of potency, moving 
from pluripotent to multi to oligo and finally to unipotent. Pluripotent cells, which adults lack, 
can turn into anything with the exception of extra embryonic structures like the placenta 
(Brazier, 2018).  Multi-potent cells are generally a specific type of cell such as a blood cell and 
can become any cell of their lineage. These cells become oligo-potent when they differentiate 
into a specific type of blood cell such as a white blood cell, which can only form other cells in its 
category. A unipotent cell can only differentiate into one type of cell and divides continuously 
(Zakrzewski, 2019). 
 While adults still have multi-potent cells, these are limited to specific sites in the body, 
primarily the bone marrow. They are often referred to as mesenchymal stem cells and are good at 
rebuilding bone and cartilage (Brazier, 2018). For this reason, scientists are primarily 
investigating these cells and induced pluripotent cells for stem cell therapy to regenerate 
cartilage. Adult stem cells can also be harvested from your own bone marrow or obtained from a 
donor and used. However, they can only repair damage to tissues or organs in the specific area of 
the body they come from as they are already specialized (Cafasso, 2016). Induced pluripotent 
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cells are created by genetically reprogramming adult somatic cells (Brazier, 2018). This gives 
them the ability to change into any needed cell, even more stem cells (NIH, 2016). The problem 
with these cells though is that they could lead to cloning in the future. They have the potential to 
form a human embryo and therefore, could create a genetic replica of the adult they were 
originally taken from. (Cafasso, 2016). 
 Due to the issues mentioned with induced pluripotent and adult stem cells as well as the 
potential of multi-potent stem cells to aid in cartilage regeneration, mesenchymal stem cells are 
currently thought to be the best ones to use for stem cell therapy. Regenexx, one of the primary 
stem cell providers in the United States, uses almost exclusively mesenchymal stem cells. These 
cells are removed from the bone marrow of the hip of either the patient having the procedure 
done or a donor. Then, they are centrifuged in the lab to get the highest quantity of stem cells per 
volume possible. After, the stem cells are injected into the precise spot of the damage, which is 
predetermined imaging- CT, x-ray, or MRI usually. If the stem cells are not being injected 
immediately, they have to be stored very carefully at negative eighty degrees Celsius (Regenexx, 
2019). In treatments, the stem cells can be combined with platelet rich plasma or ozone (Noth et 
al., 2008). Many clinics are recommending a plan that includes some combination of PRP, 
ozone, and stem cells injections as well as therapy. Although, some offer solely stem cells, 
intravenous stem cells, other types of injections, or a different package of services.  
 Since stem cells are a new area of research, there are a wide variety of treatment options 
and it can be difficult to determine which will work best. This research examined the perceived 
effectiveness of stem cell therapy and similar accompanying therapies in patients with recent 
joint injuries, specifically to the hip, knee, and shoulder, who were otherwise candidates for 
surgery or traditional methods of rehabilitation. Patients who had undergone stem cell injections 
Effectiveness of Stem Cell Injections  9 
 
in their joints were studied by conducting surveys to determine the perceived success rate and the 
treatment protocols used. Overall, this cutting edge treatment is being used more regularly to 
treat cartilage damage in the back, knees, hips, and other joints and this data will be used to 
educate potential patients by giving them patients’ perspectives on treatment effectiveness and 
best protocols as well as information to determine whether he or she is an ideal candidate.  
Approach/Methodology 
Participants 
 People of any age that underwent stem cell injections were eligible to participate in the 
study. Males and females were recruited primarily from two clinics- SC Stem Cell in Columbia, 
South Carolina and Elite Chiropractic Healthcare in Charleston, South Carolina. Additionally, 
participants were recruited from several Facebook groups for people undergoing stem cell 
therapy and on stem cell forums to gain more participants. 
 An introductory email with a link to the survey was prepared and sent to the clinic 
patients along with a message from the medical professionals asking their patients to participate 
in the study. Paper copies of the survey were also kept in the medical offices. On social media, a 
message explaining the research with a link to the survey was posted.  The message included a 
statement that all data would only be used for the purpose of this study. In order to gather more 
participants, emails and social media posts were generated multiple times. Since stem cells are a 
fairly new method of treatment, several avenues were pursued to get an adequate sample size. 
Procedures 
 For the study, participants were asked to complete a multi-part survey. The primary 
survey consisted of two sections created for this study, including questions on the stem cell 
treatment plan, how the joint was injured, other treatments tried, and the results of the injection. 
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Additionally, three surveys that have established scoring systems were used: the Knee 
Osteoarthritis Outcome Score(KOOS), the Hip Osteoarthritis Outcome Score (HOOS) and the 
Oxford Shoulder Score (OSS).  People who injured their hip, knee, or shoulder joint completed 
the secondary survey specific to the hurt joint after completion of the primary two sections.  
Measures 
Demographics and Health History. Participants reported their age range, ethnicity, race and 
gender. Then, they specified which joint or joints had received the stem cell injection in, how the 
joint was injured, and any other prior treatments used.  
Treatment Protocol. All participants were asked to specify their treatment protocol based on 
duration, single or multiple stem cell injections, and whether or not they were engaging in post 
injection physical therapy. They also included if they received other shots such as platelet rich 
plasma or PRP along with the stem cell injections.  
Treatment Results. Participants self-reported the results of their treatments as well as their pre-
treatment pain levels. Specific questions asked can be found in Table 1. Participants specified if 
they followed a treatment protocol and if so, the duration of it. The survey also had those who 
had received other types of injections rate whether or not they felt those were beneficial. Finally, 
it inquired as to their pain and mobility level compared to before, whether or not they felt the 
stem cell treatment was successful and if they would recommend it to others.   
 Following these sections, participants were asked to complete one of three surveys 
commonly used to assess joint pain and injuries depending on where they received the stem cell 
injection. These three surveys targeted those who had injured their hip, knee, and shoulder and 
were completed considering how the joint felt post-stem cell treatment.  
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Knee Osteoarthritis Outcome Score (KOOS) (Roos et al., 1998). The KOOS is shown to be 
reliable and responsive in patients undergoing surgery and physical therapy for a variety of 
conditions including osteoarthritis and ACL reconstruction (Roos et al., 1998). It has five sub-
scales that are scored individually: KOOS Pain, KOOS Symptoms, KOOS Activities of Daily 
Living (ADL), KOOS Sport/Recreation, and KOOS Quality of Life (QOL). Each question on the 
KOOS is scored from 0 to 4, with 0 being no problems and 4 being extreme problems. Then, the 
question scores are combined and divided by 4 to find the section scores. Sub-scales are scored 
from 0 to 100, with 0 representing extreme issues and 100 being no problems. 
Hip Osteoarthritis Outcome Score (HOOS) (Nilsdotter, A. & Bremander, A., 2011). The HOOS 
is very similar to the KOOS except it is designed to evaluate symptoms and functional 
limitations of the hips instead of the knees. It measures the same five outcomes as the KOOS: 
pain, activities of daily living, other disease specific symptoms, sport and recreation function, 
and hip related quality of life (Nilsdotter et al., 2003). It is also scored on the same scale. Each 
question is scored from 0 to 4, with 0 being no problems and 4 being extreme problems. 
Question scores are summed and divided by 4 to find the total section score, which ranges from 0 
to 100 with 100 being no issues and 0 equating to extreme problems. The HOOS has been tested 
and is shown to be valid and reliable in people with hip disability and hip osteoarthritis. 
Additionally, it is helpful to use on patients pre and post total hip replacement (Nilsdotter, A. & 
Bremander, A., 2011). 
Oxford Shoulder Score (OSS) (Angst et al., 2011). The OSS is a twelve question survey that 
assesses pain and function of the shoulder joint. It is scored on a five Likert scale, 1 = no 
pain/easy to do, 2 = mild pain/little difficulty, 3 = moderate pain/moderate difficulty, 4 = severe 
pain/extreme difficulty, and 5 = unbearable/impossible to do, and is primarily used on patients 
Effectiveness of Stem Cell Injections  12 
 
who have shoulder injuries or have undergone shoulder surgery (Angst et al., 2011). Overall, the 
Oxford is scored on a scale that goes from 0 to 48. The lower ranges like 0 to 19 indicate that one 
has a severe problem and is more likely to need surgery than the higher ranges. People who score 
around 48 usually have minor injuries and a good joint mobility.  OSS has a high internal 
consistency and is considered a valid and reliable measure of patient well-being (Dawson & 
Fitzpatrick, 2014). 
Data Analysis. Descriptive statistics including frequency were used to determine participant 
demographics and the rate at which each joint is injured. Mean and standard deviation were 
calculated for each survey section of the Hip Osteoarthritis Outcome Score survey and the Knee 
Osteoarthritis Outcome Score survey as well as overall for the Oxford Shoulder Score survey. 
The number of people that used each type of alternative treatment and that injured their knee 
each way (degeneration, sports, etc.) were calculated. The self-reported number of pain levels 
decreased was also totaled. Lastly, the percentage of overall success and the total number of 
successful outcomes for each joint were found. 
Results 
Participant Characteristics. Twenty-nine people participated in the survey. Demographic 
information can be found in Table 2. The majority of participants were females (65.5%). Most of 
the participants were also white, non-Hispanic or Latino and between the ages of 61 and 75. 
Injuries, Stem Cell Protocols and Alternative Treatments. Thirteen participants received stem 
cell injections in more than one joint (44.8%). The most commonly injured joint was the knee 
(72.4%). Shoulders and other joints followed, accounting for 17.2% of injuries each (Figure 1). 
Joint injuries were attributed to a variety of causes including accidents (falling), car wrecks and 
daily activities (Figure 2). Most people attributed their injuries to degeneration (58.6%) and 
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playing sports (34.5%). Additionally, twenty-five people (86.2%) reported having at least one 
other treatment such as a cortisone injection or physical therapy, prior to receiving stem cells 
(Figure 3). 
 Twenty-four survey participants (82.8%) followed a treatment protocol or schedule given 
to them by their doctor, which generally included other injections or physical therapy in addition 
to the stem cell injection. Protocols were primarily three to six months or six months to a year-
long. During treatment, only three patients (10.3%) reported receiving more than one stem cell 
injection in a joint. However, thirteen people (44.8%) were given other injections beside stem 
cells during their protocol. The most common other injection received was platelet rich plasma 
or PRP (31%). 
Pain Levels and Treatment Success. Prior to receiving stem cells, 89.7% of participants placed 
their pain level as moderate or extreme. Post treatment 79.3% of participants rated their pain 
level lower than it was before the injection and 89.7% reported at least a slight improvement in 
their level of mobility (Figure 4). Participants that received other injections, such as PRP 
mentioned above, with the stem cells were asked if those were beneficial post treatment as well. 
The majority of the people that received PRP (n=12) reported at least a slight improvement.  
 Seventy-seven percent of people believed the stem cell treatment was successful (Figure 
5). Additionally, 72% said that they would recommend it to someone with a similar injury to 
themselves. When the success rate is broken down by joint, the knee had an 85% success rate 
(Figure 6). Not as many people underwent injections in the shoulder (13%), hip (11%), and back 
(8%) but for those that did, the results are mixed.  
 Participants who had knee, hip, or shoulder injuries filled out the KOOS, HOOS, or OSS, 
respectively. Eighteen people completed the KOOS. The lowest scoring sub-scale overall was 
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the sports/recreation section with an average of 51.7 (Table 3). The section people had the least 
difficulty with after the injection was the activities of daily living. The average score for all 
participants was 77.1 (Table 3). The lowest scoring sub-scales overall for the HOOS were quality 
of life and sports/recreation as can be seen in Table 3. Activities of daily living were the highest 
scoring section post stem cell treatment for the hip. The OSS was completed by three people. 
They scored 13, 28, and 33 on it respectively (Table 4). Higher scores indicate better mobility 
and quality of life after the stem cell injection.  
Discussion  
 The purpose of this study was to examine the perceived effectiveness of stem cell 
treatment on regenerating cartilage in joints. Overall, this study found that participants believed 
the stem cell treatment successfully relieved some of their suffering from cartilage degeneration 
or lesions due to acute trauma or chronic wear and tear (77%). Participants also said they 
experienced more joint mobility and less pain post-stem cell treatment. However, the reported 
KOOS and HOOS results following the stem cell injections showed sports and recreational 
activities were still a struggle for many people. On the other hand, people stated they had an 
easier time performing activities of daily living and a better quality of life after treatment.  
 Several other research studies found similar results when assessing the effectiveness of 
stem cells. A randomized control study was conducted on patients with evidence of 
osteoarthritis, who had not responded to other treatments (Vega et al., 2015). The participants 
received either a stem cell injection or a hyaluronic acid injection. Another similar clinical trial 
performed using stem cells assessed the effectiveness and optimal dosage of stem cells (Gutpa et 
al., 2016). In both studies, there were significant improvements in pain and function after a 
yearlong period and it was concluded that there is a trend toward efficacy with stem cell 
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treatment, especially at a twenty-five million stem cell dosage (Vega et al., 2015 & Gutpa et al., 
2016). The promising results of these studies show that stem cells may have the potential to be 
used as a primary treatment for osteoarthritis and other injuries. They also indicate that stem cell 
injections may be a viable alternative to joint replacements for patients suffering from 
osteoarthritis. Going forward, more research is needed to see the long-term implications of stem 
cell treatment. This should include the duration of effectiveness (if there is one) and if there are 
any adverse effects of the treatment.    
 Twenty-three participants (79.3%) stated that their pain improved at least one level post 
stem cell treatment, typically decreasing from a moderate pain level to a mild one or from mild 
to no pain at all. Additionally, twenty-two participants (75.9%) stated that their mobility was 
moderately or vastly improved afterwards. Another study conducted by injecting stem cells into 
patients’ knee joints supported these results (Kubsik-Gidlewska et al., 2018). They found that 
patients had better mobility, lower levels of pain, and more cartilage in their knees post-treatment 
(Kubsik-Gidlewska et al., 2018). These finding are significant because better levels of mobility 
will allow patients to live healthier lives and reduce their chances of developing other chronic 
diseases. People with osteoarthritis that stay active as they age are more likely to maintain a 
healthy weight, less likely to suffer from depression and have a reduced fear of falling (Penninx 
et al., 2001). That being said, more trials that evaluate participants prior to and post-stem cell 
injection need to be conducted to identify how much mobility, pain, and cartilage growth are 
altered as well as the effect stem cell treatment has on people’s ability to stay active as they age.  
 The majority of patients (n=21) in the study received stem cell injections in their knees. 
In the knees, the reported success rate was 85%. Shoulder, hip, and back injections were also 
analyzed but the sample size was not great enough in these groups to draw any conclusions. A 
Effectiveness of Stem Cell Injections  16 
 
trial performed on retired NFL players also saw success in the knees as well as the hips and 
shoulders (Pettine et al., 2018). In the study, participants underwent a baseline evaluation prior to 
receiving a stem injection in their osteoarthritic joint. A year later the evaluations were repeated, 
and participants scored  at a minimum 62%, 40%, and 64% higher on knee, shoulder and hip 
tests, respectively. (Pettine et al., 2018).  The improvement and success rates shown here are 
dramatic and support stem cell therapy as an alternative to surgery. These findings also further 
demonstrate that stem cells could be a viable treatment for people with osteoarthritis. However, a 
group of osteoarthritis patients that receives stem cells needs to be followed for many years to 
identify if joint replacement can be completely avoided and if not, how long it is delayed.  
 The KOOS scores in this study were self-reported following the stem cell treatment. 
Then, they were compared to other studies that used the KOOS to conduct both pre and post 
assessments. Activities of daily living and pain mean scores were 77.1 and 72.1, respectively. 
Another study reported post-treatment KOOS scores of 80 on activities of daily living and 72 on 
pain (Chahal et al., 2019). A third research article also published similar findings with a score of 
82 on both sections (Nilsodotter et al., 2009). Quality of life and sports/recreation were the two 
lowest scoring sections across all three studies (Chahal et al., 2019 and Nilsdotter et al., 2009). 
The sports and recreation score was 51.7 in this study compared to 48 in the other two (Chahal et 
al., 2019 and Nilsodotter et al., 2009). These results demonstrate that stem cell treatment can 
make a profound difference in people’s lives by allowing them to perform day to day activities 
with reduced or no pain. In the future, similar research needs to be conducted with a larger group 
of people and on all of the major joints in which people are receiving stem cell therapy.  
 This study had several limitations. Primarily, the sample size was small and the duration 
of the research was short. Therefore, it was difficult to draw definitive conclusions. The 
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participants also were not very diverse as the majority were white adults over the age of 45. This 
survey analysis also had many strengths, namely it demonstrated the need for more research to 
be done on stem cell injections, a relatively new method of treatment for injuries and 
osteoarthritis. Additionally, the study was completed in a short period of time and had no 
associated costs.  
Conclusion 
 Overall, this research identified that the majority of people are self-reporting stem cell 
injections to be effective and to better their quality of life. They also report that stem cell 
treatment improves their mobility and decreases their pain and other symptoms. These outcomes 
show that stem cell therapy warrants further study. It is a rapidly expanding area of research in 
the scientific community and has the potential to become a standard method of treatment for 
osteoarthritis and joint injuries. Hopefully, more patients will see stem cell treatment as a viable 
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Tables and Figures 


























How would you describe your pre-stem cell treatment level of pain? 
No pain or 
discomfort 
Mild pain or 
discomfort 
Moderate pain or 
discomfort 
Extreme pain or discomfort 
How would you describe your post-stem cell treatment level of pain? 
No pain or 
discomfort 
Mild pain or 
discomfort 
Moderate pain or 
discomfort 
Extreme pain or discomfort 
How would you compare your pre-treatment activity/mobility level to your level now? Please consider 
where you were just before treatment. 
Vastly Improved Moderately Improved Slightly Improved No change Worse 
Generally speaking, do you believe the stem cell treatment was successful? 
Yes No 
After having the stem cell treatment, would you recommend it to other patients with a similar injury? 
Yes No Unsure 
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Table 2: Population Demographics  
Characteristic N Frequency (%) 
Gender   
Male 10 34.5 
Female 19 65.5 
Ethnicity   
Hispanic or Latino 1 3.5 
Not Hispanic or Latino 28 96.6 
Race   
White 27 93.1 
American Indian or Alaska Native 1 3.5 
Asian 1 3.5 
Age Range   
15-30 1 3.5 
31-45 6 20.7 
46-60 8 27.6 
61-75 14 48.3 
 
 








Quality of Life 
Mean 72.1 70.1 77.1 51.7 55.7 
Standard 
Deviation 








Quality of Life 
Mean 68.3 67.9 77.9 39.6 37.5 
Standard 
Deviation 
14.5 21 19.8 20.6 13.5 
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Table 4: Oxford Shoulder Score (OSS) Outcomes (n=3) 
Participants Total Score (0 to 48) 
Mean 24.7 
Standard Deviation 8.5 
 
Figure 1: Injured Joint* (n=29) 
 
*Participants could indicate injuries to multiple joints 
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Figure 3: Alternative Treatments Utilized 
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Figure 5: Stem Cell Treatment Outcomes (n=29) 
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